
The former ‘party drug’ ketamine has gotten some good press recently, with clinical trials suggesting it might be a powerful and fast-acting antidepressant. Now, one of the first “real-world” studies of ketamine against depression appears to support those findings. Researchers at the University of Michigan and the VA Ann Arbor Healthcare System say that almost half of 215 veterans who’d been suffering severe, treatment-resistant depression benefited from six weeks of ketamine infusions. “It’s not a silver bullet,” stressed study lead author Dr. Paul Pfeiffer. “But when we see these patients in our clinic, who have been through every treatment available and nothing has worked, to have even a quarter achieve a significant measurable response is very good. We routinely get thanked for making a difference in their lives.” Pfeiffer led the study with Dr. Avinash Hosanagar. Both are faculty at the U-M Medical School department of psychiatry, and both treat patients in the VA Ann Arbor Healthcare System. The veterans involved in the new study were selected because they’d all tried and failed multiple treatments to curb their severe depression. Many had other mental health issues, such as post-traumatic stress disorder (PTSD), anxiety or a history of alcohol or drug abuse. The Michigan researchers had each of the patients receive ketamine infusions beginning in 2019 or the first nine months of 2020. Their outcomes were tracked… read on > read on >